44.200.171.74
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Oculoplastics

Substantial proportion of patients with Graves’ disease have thyroid eye disease

Posted on September 8, 2020

Worldwide, 40% of patients with Graves’ disease have thyroid eye disease (TED), according to a study published in Clinical Endocrinology.

Researchers found that the pooled prevalence of TED was

-38% for Europe

-44% for Asia

-27% for North America

-58% for Oceania.

In Southeast Asia and the Middle East, TED prevalence as 35% and 48%, respectively.

Predominantly Caucasian regions had a lower prevalence of TED compared to Asians

The most common clinical manifestation included lid retraction (57%), proptosis (57%), diplopia (36%), and ocular hypertension (13%).

Reference
Chin YH, Cheng HN, Ming HL, et al. Prevalence of thyroid eye disease in Graves’ disease: A meta‐analysis and systematic review. Clin Endocrinol. 2020; ttps://doi.org/10.1111/cen.14296

-Advertisement-
Related Articles
Gail Devers Partners with the Graves’ Community to Focus on Thyroid Eye Disease
Jul 15, 2021
Gail Devers, Three-Time Olympic Gold Medalist, Partners with the Graves’ Community to FOCUS on Thyroid Eye Disease
Jul 12, 2021
Mycophenolate mofetil appears to be effective second-line treatment for TED
Jun 01, 2021
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-